Loratadine PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Loratadine PCD pharma franchise company offering a portfolio of 8 Loratadine formulations. We supply quality-assured, consistently manufactured Loratadine products to franchise partners and distributors across India on a monopoly (district-wise) basis.

What is Loratadine?

Loratadine is a second-generation, non-sedating H1 antihistamine that selectively blocks peripheral histamine H1 receptors, preventing the sneezing, itching, rhinorrhoea and wheals triggered by histamine during allergic reactions. Because it poorly crosses the blood-brain barrier, it causes little drowsiness. Reference: PubChem.

Available Forms

Our Loratadine range is available as Suspension and Tablets, allowing partners to serve diverse prescriptions from a single reliable supplier.

Therapeutic Applications of Loratadine

Loratadine is indicated for allergic rhinitis (seasonal and perennial) and chronic idiopathic urticaria, providing relief from sneezing, nasal itching, runny nose and hives. It is commonly prescribed by ENT specialists, dermatologists, paediatricians and general physicians.

Why Loratadine is a High-Potential Molecule for Distributors

Allergic rhinitis and urticaria affect a very large population year-round and peak sharply in allergy seasons, making non-sedating antihistamines a high-volume, fast-moving category. With both a paediatric suspension and adult tablets, Loratadine lets distributors capture family-wide, repeat OTC-style demand.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent pricing and dependable supply chain help distributors build a profitable long-term business.

References

1. WHO Model List of Essential Medicines
2. PubChem - Loratadine
3. PubMed - Loratadine research